{
  "Variants Include": [
    {
      "Gene": "Unknown",
      "variants": [
        {
          "HGVS": "Unspecified (based on context)",
          "cDNA Change": {
            "transcript": "Unspecified",
            "ref": "Unknown",
            "alt": "Unknown",
            "position": "Unknown"
          },
          "Protein Change": {
            "ref": "Unknown",
            "alt": "Unknown",
            "position": "Unknown"
          },
          "Description in input context": "This variant causes a structural change in the protein, affecting its function."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Amyotrophic Lateral Sclerosis (ALS)",
    "MONDO": "MONDO:0004865"
  },
  "Experiment Method": [
    {
      "Assay Method": "Unknown",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 or Neuron-specific cells (based on context)",
        "Description": "The experiment was conducted using a combination of HEK293 and neuron-specific cells to study the effects of the variant."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "Unspecified (based on context)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Intermediate effect",
          "Result Description": "Protein expression was affected by the variant, showing an intermediate effect."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA or wild-type protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or no cDNA/protein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "'t-test' or 'ANOVA' was used for statistical analysis, based on the context."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}